JB Chemicals & Pharmaceuticals (JB Pharma) CEO Nikhil Chopra stated that the company is looking into possible acquisitions of brands and portfolios in order to gain a foothold in the diabetes segment. "In the world of metabolics, we'd like to...
Beta Drugs Ltd (Adley Group) has received approval from the Drug Controller General of India (DCGI) to market Enzalutamide 160 mg under the brand name ADLEAP. This medicine was developed by the company to provide a much-needed treatment option for...
Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced that the US Food and Drug Administration (FDA) accepted Delcath's (Delcath) new drug application resubmission for...
The Central Drugs Standard Control Organization has granted Sanofi (India) marketing authorization for their diabetes medicine Soliqua (in pre-filled pen). (CDSCO)....
Drug development is a very complex process that takes years and costs billions of dollars. According to the Tufts Center for the Study of Drug Development, the average cost of developing a new drug is $2.6 billion, and it takes an average of 10 years
In a pivotal trial, Novartis' Kisqali breast cancer medication reduced the risk of recurrence in patients with early-stage disease diagnosis, boosting the company's growth prospects...
Lupin Limited has announced the successful completion of the inspection carried out at its Pithampur facilities in India...
On the occasion of World Tuberculosis Day, the World Health Organization (WHO) announces the expansion of the WHO Director-(DG) General's Flagship Initiative on tuberculosis from 2023 to 2027 to support faster progress towards ending TB and...
"Given healthy growth prospects, players rated by CRISIL Ratings have intensified bed expansion, including brownfield, since fiscal 2023," asserted Poonam Upadhyay, director of CRISIL Ratings...
.jpg)
Indian pharmaceutical companies are planning to increase their research spending in the next five years duration. The Indian pharmaceutical market is projected to grow and reach $130 bn in the next ten years.
, CDSCO.jpg)
